Dr.Ashavin'S Lab Services (Opc) Private Limited - Due diligence report

A 360° intelligence report on Dr. Ashavin'S: trust score, financial health, credit view, compliance, directors, growth and distress signals …

2017-09-04 Chandigarh, Chandigarh Active Unlisted Active Compliant
Share
Connect MCP
DL Dr.Ashavin'S Lab Services (Opc) Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Dr. Ashavin'S — 360° Intelligence Report

Generated from MCA filings & public records
60/100
Trust Score
Moderate

Dr. Ashavin'S is assessed as Moderate with a Trust Score of 60/100. Dr. Ashavin'S is an active company incorporated in 2017, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 18 Aug 2026 from the latest processed filings. Dr.Ashavin'S Lab Services (Opc) Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
60/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
70/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
40/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 4 open (53.50 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others4 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 70/100
NameDIN / PANDesignationAppointedTenureDIN status
ASHVIN KUMAR AGGARWAL 01234567 Director 01/04/2018 6 yrs Approved
  • Board below statutory minimum.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 40
Growth signals & trust indicators
Revenue acceleration: +38% over 2 year(s).
Operating for 8 years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Negative net worth.
4 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence70/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment44/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 4 open charge(s) of 53.50 Lakh already registered.
  • Compliance record supports lending.
Investor view45/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
31 Mar 2025
Latest balance sheet
Filed with ROC
16 Jun 2023
Charge created
Others - 15.00 Lakh
Charge created
Others - 10.00 Lakh
09 Apr 2019
Charge created
Others - 12.50 Lakh
05 Feb 2019
Charge created
Others - 16.00 Lakh
04 Sep 2017
Incorporated
Registered with Roc Chandigarh
Director appointed
ASHVIN KUMAR AGGARWAL (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 2 financial year(s).
Net profit margin moved from 2.1x to 24%.
Compliance record is strong - status, filings and flags are clean.
1 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Reidffmail U24111KA1991PTC011853 Bangalore, Karnataka, India
Lifemax Pharmaceutical U24232RJ2011PTC036870 Jaipur, Rajasthan, India
Parul-Shway Herbals Private Limited U24246DL2004PTC126293 New Delhi, Delhi, India
Aloft Chemicals Private Limited U24100MH2004PTC148518 Raigarh, Maharashtra, India
Gale Pharma (India) Private Limited U51909TG2013PTC087583 Hyderabad, Telangana, India
Sri Biosphere Private Limited U24233TG2015PTC098109 Hyderabad, Telangana, India
Glonest Pharma Private Limited U51909MH2019PTC329852 Navi Mumbai, Maharashtra, India
Kprgroup U24233AP2011PLC076877 Balabhadrapuram, Andhra Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Dr. Ashavin'S before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Dr. Ashavin'S: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Dr. Ashavin'S - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 60/100, distress signals and MSME payment-delay disclosures - know whether Dr. Ashavin'S pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Dr. Ashavin'S - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Dr. Ashavin'S an active company?

Dr. Ashavin'S has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Dr. Ashavin'S financially healthy?

Dr. Ashavin'S has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Dr. Ashavin'S?

Its overall Trust Score is 60/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Dr. Ashavin'S?

See the directors and ownership sections above for board and shareholding detail. 1 active director(s) are on record.

Does Dr. Ashavin'S have loans or charges against its assets?

4 open charge(s) are registered against its assets.

Is Dr. Ashavin'S up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Dr. Ashavin'S?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.